Incretin effect is sufficient for glucose control in developing rats.

Hyperglycemia is common in extremely preterm infants, and the treatment of neonatal hyperglycemia should be associated with a low risk of hypoglycemia. Incretin-based therapies are characterized by a low risk of hypoglycemia and are efficacious and s…

Preview only. Read the full abstract at the source